DREADD activation of the lateral orbitofrontal increases cocaine-taking and cocaine-seeking in male and female rats during intermittent access self-administration under risky conditions.
Addiction
Cocaine
Negative consequences
Orbitofrontal cortex
Punishment
Rat
Journal
Addiction neuroscience
ISSN: 2772-3925
Titre abrégé: Addict Neurosci
Pays: Netherlands
ID NLM: 9918367980706676
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
medline:
28
8
2023
pubmed:
28
8
2023
entrez:
28
8
2023
Statut:
ppublish
Résumé
Addiction is a disorder that can be characterized in part as the constant pursuit of a particular substance despite negative consequences. Although the orbitofrontal cortex (OFC) is known to regulate risk-taking more generally and be critical to the development of addiction, its role in regulating drug use under risk-taking conditions is unknown. To address this, we examined drug-taking and drug-seeking in male and female rats under conditions where cocaine infusions were paired with foot shock punishment 50% of the time and combined this paradigm with cFos immunohistochemistry. We found that rats that showed higher levels of drug-taking and drug-seeking prior to punishment showed decreased responding during self-administration sessions under risky conditions and lower levels of c-Fos expression in the lateral but not medial OFC. However, despite these initial differences in responses to infusions paired with foot shocks, all rats showed decreased responding with additional punishment sessions. We then used chemogenetic viral approaches to examine how altering activity of the lateral OFC affects drug-taking and drug-seeking during punished drug use. Although there was no effect of G
Identifiants
pubmed: 37637005
doi: 10.1016/j.addicn.2023.100122
pmc: PMC10455039
mid: NIHMS1926093
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NIDA NIH HHS
ID : R01 DA047107
Pays : United States
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Psychopharmacology (Berl). 2020 Mar;237(3):639-654
pubmed: 31912190
Atherosclerosis. 2017 Jul;262:154-162
pubmed: 28363516
Neuron. 2019 Aug 21;103(4):734-746.e3
pubmed: 31253468
Biol Psychiatry. 2019 Jun 1;85(11):936-945
pubmed: 30737015
J Neurosci Res. 2017 Jan 2;95(1-2):260-269
pubmed: 27870448
Cereb Cortex. 2018 Mar 1;28(3):819-832
pubmed: 28057724
Science. 2004 Aug 13;305(5686):1014-7
pubmed: 15310906
Nat Neurosci. 2001 Jan;4(1):95-102
pubmed: 11135651
Psychopharmacology (Berl). 2019 Feb;236(2):625-639
pubmed: 30368583
Front Neuroendocrinol. 2008 Jan;29(1):36-47
pubmed: 17904621
Psychopharmacology (Berl). 2020 Jun;237(6):1795-1812
pubmed: 32206828
Addict Biol. 2020 Sep;25(5):e12809
pubmed: 31373148
Psychopharmacology (Berl). 1999 May;144(1):77-82
pubmed: 10379627
Front Syst Neurosci. 2016 Feb 22;10:12
pubmed: 26941618
Curr Top Behav Neurosci. 2011;8:73-96
pubmed: 21769724
Science. 2004 Aug 13;305(5686):1017-9
pubmed: 15310907
Mol Psychiatry. 2018 Mar;23(3):544-555
pubmed: 29038598
J Neurosci. 2004 Jul 21;24(29):6600-10
pubmed: 15269272
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):9066-9071
pubmed: 30988198
Cogn Affect Behav Neurosci. 2019 Dec;19(6):1404-1417
pubmed: 31342271
Neuropsychopharmacology. 2012 Jul;37(8):1901-10
pubmed: 22453139
J Neurosci. 2019 May 29;39(22):4353-4364
pubmed: 30902868
Biol Psychiatry. 2002 Jan 15;51(2):134-42
pubmed: 11822992
J Neurosci. 2011 Apr 27;31(17):6398-404
pubmed: 21525280
J Cogn Neurosci. 2014 Jul;26(7):1347-62
pubmed: 24405106
Behav Brain Res. 2013 Feb 1;238:1-9
pubmed: 23098798
Drug Alcohol Depend. 2017 Nov 1;180:401-416
pubmed: 28982092
Neuroscience. 2010 Jan 20;165(2):313-24
pubmed: 19879927
Psychopharmacology (Berl). 2016 Oct;233(19-20):3587-602
pubmed: 27481050
Neuropsychopharmacology. 2022 Jan;47(2):444-453
pubmed: 34429520
Behav Neurosci. 2021 Apr;135(2):174-181
pubmed: 34060874
Learn Mem. 2016 Oct 17;23(11):607-617
pubmed: 27918280
Neuropsychopharmacology. 2016 Mar;41(4):1128-37
pubmed: 26289144
Psychopharmacology (Berl). 2020 Oct;237(10):2929-2941
pubmed: 32556402
J Neurosci. 2016 Feb 10;36(6):1996-2006
pubmed: 26865622
Sci Adv. 2019 Oct 16;5(10):eaax1532
pubmed: 31663022
Addict Biol. 2019 Mar;24(2):251-264
pubmed: 29314464
Neuron. 2015 Dec 2;88(5):1054-1066
pubmed: 26586182